This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

James E. Dalen, MD, FCCP; Jack Hirsh, MD; James E. Dalen, MD, FCCP; Jack Hirsh, MD

Arch Intern Med. 1986;146(3):462-472.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

INTRODUCTION

Antithrombotic therapy has been recommended at one time or another for nearly every A cardiovascular disorder that is seen in daily practice.

In determining which patients should be treated, the clinician faces a most difficult task because the information for the efficacy of antithrombotic therapy for many disorders is incomplete and the recommendation to use antithrombotic therapy has been based on case series or clinical judgment. In recent years, a number of randomized studies have been performed, which have provided definitive information on the value of antithrombotic therapy in a number of cardiovascular disorders including: the prevention and treatment of venous thromboembolism; treatment of unstable angina; prevention of shunt thrombosis after aortocoronary bypass surgery, and treatment of transient cerebral ischemia. However, information is incomplete for many common disorders and there are few important areas of medicine in which the lack of consensus on appropriate management is so evident.

To . . . [Full Text PDF of this Article]

Author Affiliations
From the American College of Chest Physicians, Park Ridge, Ill.

Footnotes
Accepted for publication Jan 20, 1986.

Summaries and recommendations reprinted with permission from Chest (1986;89:1S-106S).

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?